索引超出了数组界限。
[1] Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity[J]. Endocr Pract, 2016, 22(Suppl 3):1-203.
[2] 中华医学会内分泌学分会肥胖学组.中国成人肥胖症防治专家共识[J]. 中华内分泌代谢杂志, 2011, 27(9):711-717.
[3] Lyall DM, Celis-Morales C, Ward JA, et al. Association of body mass index with cardiometabolic disease in the UK biobank: a mendelian randomization study[J]. JAMA Cardiol, 2017, 2(8):882-889.
[4] Hansen L, Netterstr?m MK, Johansen NB, et al. Metabolically healthy obesity and ischemic heart disease: a 10-year follow-up of the inter99 study[J]. J Clin Endocrinol Metab, 2017, 102(6):1934-1942.
[5] Baena-Diez JM, Byram AO, Grau MA, et al. Obesity is an independent risk factor for heart failure: zona franca cohort study[J]. Clin Cardiol, 2010, 33(12):760-764.
[6] Prospective Studies Collaboration, Whitlock G, Lewington S, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies[J]. Lancet, 2009, 373(9669):1083-1096.
[7] Song X, Tabák AG, Zethelius B, et al. Obesity attenuates gender differences in cardiovascular mortality[J]. Cardiovasc Diabetol, 2014, 13:144.
[8] Chen Y, Copeland WK, Vedanthan R, et al. Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium[J]. BMJ, 2013, 347:f5446.
[9] Wykretowicz A, Adamska K, Guzik P, et al. Indices of vascular stiffness and wave reflection in relation to body mass index or body fat in healthy subjects[J]. Clin Exp Pharmacol Physiol, 2007, 34(10):1005-1009.
[10] 董剩勇, 王曼柳, 孙晓楠, 等. 体脂肪率评估心血管危险因素研究[J]. 中国全科医学, 2015, 18(36):4416-4421.
[11] Lima-Martinez MM, Blandenier C, Iacobellis G. Epicardial adipose tissue: more than a simple fat deposit?[J]. Endocrinol Nutr, 2013, 60(6):320-328.
[12] 杜松明, 李艳平, 房红芸, 等. 不同类型肥胖与心血管疾病危险因素关联的比较[J]. 中华流行病学杂志, 2010, 31(6):626-632.
[13] 贺燕林, 郝宏毅. 冠心病患者体脂分布与冠状动脉病变程度的关系[J]. 临床心血管病杂志, 2010, 26(9):657-660.
[14] Lee JJ, Pedley A, Hoffmann U, et al. Association of changes in abdominal fat quantity and quality with incident cardiovascular disease risk factors[J]. J Am Coll Cardiol, 2016, 68(14):1509-1521.
[15] Rheaume C, Arsenault BJ, Faha J, et al. Impact of abdominal obesity and systemic hypertension on risk of coronary heart disease in men and women: the EPIC-Norfolk population study[J]. J Hypertens, 2014, 32(11):2224-2230.
[16] Hastie CE, Padmanabhan S, Slack R, et al. Obesity paradox in a cohort of 4 880 consecutive patients undergoing percutaneous coronary intervention[J]. Eur Heart J, 2010, 31(2):222-226.
[17] Clark AL, Fonarow GC, Horwich TB. Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited[J]. J Card Fail, 2011, 17(5):374-380.
[18] Oyedeji AT, Balogun MO, Akintomide AO, et al. The "obesity paradox" in Nigerians with heart failure[J]. Ann Afr Med, 2012, 11(4):212-216.
[19] Park HW, Kim KH, Song IG, et al. Body mass index, carotid plaque, and clinical outcomes in patients with coronary artery disease[J]. Coron Artery Dis, 2017, 28(4):278-286.
[20] Nochioka K, Shiba N, Kohno H, et al. Both high and low body mass indexes are prognostic risks in Japanese patients with chronic heart failure: implications from the CHART study[J]. J Card Fail, 2010, 16(11):880-887.
[21] Haass M, Kitzman DW, Anand IS, et al. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction results from the irbesartan in heart failure with preserved ejection fraction(I-PRESERVE)trial[J]. Circ Heart Fail, 2011, 4(3):324-331.
[22] Frankenstein L, Zugck C, Nelles M, et al. The obesity paradox in stable chronic heart failure does not persist after matching for indicators of disease severity and confounders[J]. Eur J Heart Fail, 2009, 11(12):1189-1194.